Gαi2-Deficient Mice with Colitis Exhibit a Local Increase in Memory CD4+ T Cells and Proinflammatory Th1-Type Cytokines

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1068-1077

  Hörnquist, C Elisabeth ^a,b   Lu, Xiaohui ^a   Rogers Fani, Pamela M ^a   Rudolph, Uwe ^a,c   Shappell, Scott ^a   Birnbaumer, Lutz ^a,d   Harriman, Gregory R ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Baker Norton Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA INTEGRIN; BETA7 INTEGRIN; CD45 ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; L SELECTIN; LEUKOCYTE ANTIGEN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LARGE INTESTINE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUCOSAL IMMUNITY; PATHOLOGY; PHYSIOLOGY; SMALL INTESTINE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; ULCERATIVE COLITIS;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; CYTOKINES; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INTEGRIN ALPHA4; INTEGRIN BETA CHAINS; INTEGRINS; INTESTINE, LARGE; INTESTINE, SMALL; L-SELECTIN; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; TH1 CELLS;

EID: 0031066597     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Reinecker, H.-C., S. Schreiber, W. F. Stenson, and R. P. MacDermott. 1994. The role of the mucosal immune system in ulcerative colitis and Crohn's Disease. In Handbook of Mucosal Immunology, P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock, eds. Academic Press, San Diego, CA, p.439.
2. Ferreira, R. da C., L. E. Forsyth, P. I. Richman, C. Wells, J. Spencer, and T. T. McDonald. 1990. Changes in the rate of crypt epithelial cell proliferation and mucosal morphology induced by a T-cell-mediated response in human small intestine. Gastroenterology 98:1255.
3. + T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur. J. Immunol. 23:664.
4. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275.
5. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and L. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
6. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
7. Holländer, G. A., S. J. Simpson, E. Mizoguchi, A. Nichogiannipoulou, J She, J.-C. Gutierrez-Ramos, A. K. Bhan, S. J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis in mice with aberrant thymic selection. Immunity 3:27.
8. + T cells induce or protect from chronic intestinal inflammation in C.B-17 seid mice. Int. Immunol. 5:1461.
9. Birnbaumer, L. 1992. Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits. Cell 71:1069.
10. Rudolph, U., M. J. Finegold, S. S. Rich, G. R. Harriman, Y. Srinivasan, P. Brabet, A. Bradley, and L. Birnbaumer. 1995. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nature Genet. 10:143.
11. Elson, C. O., W. Ealding, and J. Lefkowitz. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immunol. Methods 67:101.
12. Harriman, G. R., N. Y. Lycke, L. J. Elwood, and W. Strober. 1990. T lymphocytes that express CD4 and the alpha/beta-T cell receptor but lack Thy-1: preferential localization in Peyer's patches. J. Immunol. 145:2406.
13. + lamina propria T cell lines: phenotypic and functional characterization. Immunology 75:66.
14. Lycke, N. 1986. A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells. Scand. J. Immunol. 24:309.
15. Eckman, L., J. Fierer, and M. F. Kagnoff. 1996. Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J. Immunol. 156:2894.
16. Truong, L. D., A. Farhood, J. Tasby, and D. Gillum. 1992. Experimental chronic renal ischemia: morphologic and immunologic studies. Kidney International 41: 1689.
17. Gallatin, W. M., I. L. Weissman, and E. C. Butcher. 1983. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30.
18. Holzmann, B., B. W. McIntyre, and I. L. Weissman. 1989. Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an α chain homologous to human VLA-4α. Cell 56:37.
19. Kilshaw, P. J., and S. J. Murant. 1991. Expression and regulation of β7 (βp) integrins on mouse lymphocytes: relevance to the mucosal immune system. Eur. J. Immunol. 21:2591.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
21. Manetti, R., P. Parronchi, M. G. Guidizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor IL-12 induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J. Exp. Med. 177:1199.
22. + T cells to enhance priming for interferon-γ production and diminishes interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
23. Ma, A., M. Datta, E. Margosian, J. Chen, and I. Horak. 1995. T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med. 182:1567.
24. + T cells in the pathogenesis of murine inflammatory bowel disease. Eur. J. Immunol. 24:2803.
25. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissmann, A. Hamann, and E. C. Butcher. 1993. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.
26. Karecla, P. I., S. J. Bowden, S. J. Green, and P. J. Kilshaw. 1995. Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin αM290β7 (αEβ7). Eur. J. Immunol. 25:852.
27. Cepek, K. L., S. K. Shaw, C. M. Parker, G. J. Russell, J. S. Morrow, D. L. Rimm, and M. B. Brenner. 1994. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 372:190.
28. Chensue, S. W., J. H. Ruth, K. Warmington, P. Lincoln, and S. L. Kunkel. 1995. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155:3456.
29. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis alpha. J. Exp. Med. 181:1615.
30. Hayes, M. P., J. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646.
31. Isaacs, K. L., R. B. Sartor, and S. Haskill. 1992. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587.
32. Casini-Raggi, V., L. Kam, Y. J. T. Chong, C. Fiocchi, T. T. Pizarro, and F. Cominelli. 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. J. Immunol. 154:2434.
33. 2 from activated eosinophils and macrophages in ulcerative colitis. Am. J. Gastroenterol. 90:614.
34. Niessner, M., and B. A. Volk. 1995. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101:428.
35. Capello, M., S. Keshav, C. Prince, D. P. Jewell, and S. Gordon. 1992. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridization. Gut 33:1214.
36. Eliakim, R., F. Karmeli, E. Razin, and D. Rachmilewitz. 1988. Role of platelet-activating factor in ulcerative colitis: enhanced production during active disease and inhibition by sulfasalazine and prednisone. Gastroenterology 95:1167.
37. Rampton, D. S., and G. E. Sladen. 1984. The relationship between rectal mucosa prostaglandin production and water and electrolyte transport in ulcerative colitis. Digestion 30:13.
38. Mayer, L., and R. Shlien. 1987. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166:1471.
39. Mayer, L., and D. Eisenhardt. 1990. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease. J. Clin. Invest. 86:1255.
40. Cerf-Bensussan, A. Quaroni, J. T. Kurnick, and A. K. Bhan. 1984. Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J. Immunol. 132:2244.
41. Colgan, S. P., C. A. Parkos, J. B. Matthews, L. D'Andrea, C. S. Awtrey, A. H. Lichtman, C. Delp-Archer, and J. L. Madara. 1994. Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am. J. Physiol. 267:C402.
42. Madara, J. L., and J. Stafford. 1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724.
43. Colgan, S. P., C. A. Parkos, C. Delp, M. A. Arnaout, and J. L. Madara. 1993. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-gamma in a highly polarized fashion. J. Cell Biol. 120:785.
44. Yang, H. Y., and J. I. Rotter. 1995. Genetic aspects of idiopathic IBD. In Inflammatory Bowel Disease, 4th Ed. J. B. Kirsner and R. G. Shorter, eds. Williams & Wilkins, Baltimore, MD, p. 301.
45. Serreze, D. V., and E. H. Leiter. 1994. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr. Opin. Immunol. 6:900.
46. Gasser, D. L., J. Palm, and N. K. Gonatas. 1975. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J. Immunol. 115:431.
47. Bernard, C. C. A. 1976. Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet. 3:263.
48. Sartor, R. B. 1995. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation. In Inflammatory Bowel Disease, 4th Ed. J. B. Kirsner and R. G. Shorter, eds. Williams & Wilkins, Baltimore, MD, p. 96.
49. Sartor, R. B. 1990. Role of intestinal microflora initiation and perpetuation of inflammatory bowel disease. Can. J. Gastroenterol. 4:271.
50. Duchmann, R., I. Kaiser, E. Hermann, W. Mayet, K. Ewe, and K.-H. Meyer zum Büschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102:448.
51. Taurog, J. D., J. A. Richardson, J. T. Croft, W. A. Simmons, M. Zhou, J. L. Fernandez-Sueiro, E. Balish, and R. E. Hammer. 1994. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180:2359.
52. Fox, J. G., F. E. Dewhirst, J. G. Tully, B. J. Paster, L. Yan, N. S. Taylor, M. J. Collins, Jr., P. L. Gorelick, and J. M. Ward. 1994. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J. Clin. Microbiol. 32:1238.
53. Chaffin, K. E., and R. M. Perlmutter. 1991. A pertussis toxin-sensitive process controls thymocyte emigration. Eur. J. Immunol. 21:2565.
54. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821.
55. Bargatze, R. F., and E. C. Butcher. 1993. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J. Exp. Med. 178:367.
56. ras mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268:22235.
57. raf-1. J. Biol. Chem. 268:20717.
58. Offermanns, S., E. Bombien, and G. Schultz. 1993. Stimulation of tyrosine phosphorylation and mitogen-activated protein (MAP) kinase activity in human SH-SY5Y neuroblastoma cells by carbachol. Biochem. J. 294:545.
59. Winitz, S., M. Russell, N. X. Qian, A. Gardner, L. Dwyer, and G. L. Johnson. 1993. Involvement of Ras and Raf in the Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. J. Biol. Chem. 268:19196.
60. Montmayeur, J.-P., and E. Borrelli. 1994. Targeting of Gαi2 to the Golgi by alternative spliced carboxyl-terminal region. Science 263:95.
61. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593.
62. Valet, P., J. M. Senard, J. C. Devedjian, V. Planat, R. Salomon, T. Voisin, G. Drean, A. Covineau, D. Daviaud, C. Denis, M. Laburthe and H. Paris. 1993. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa. J. Clin. Invest. 91:2049.
63. Rudolph, U., K. Spicher, and L. Birnbaumer. 1996. Adenylyl cyclase inhibition and altered G protein subunit expression and ADP-ribosylation patterns in tissues and cells from Gi2α-/- mice. Proc. Natl. Acad. Sci. USA 93:3209.